RE:RE:RE:RE:Theralase = TLD-1433I know they're probably monitoring the testing meticulously and I hate to bring this up, but the conspiracy part of my personality thinks that the success of TLT's Phase 2 might bring quite a bit of pain to the stock price of other treatments. Is it possible that any of the doctors doing the test could have been 'incentivised' by some large pharma groups to alter the doses and throw off the results? I doubt they'd be able to get away with altering the likely much more closely watched second treatment, but things are pretty ruthless when this kind of money is involved. I only bring it up because the results seem like such an anamoly.